V. Howell

From mice to men: GEMMs as trial patients for new NSCLC therapies.

M. Molloy, A. Hudson, S. Hayes, 2014, Seminars in cell & developmental biology.

Treatment of ALK‐rearranged non‐small cell lung cancer: A review of the landscape and approach to emerging patterns of treatment resistance in the Australian context

N. Pavlakis, B. Solomon, M. Millward, 2017, Asia-Pacific journal of clinical oncology.

Differential effects of radiation fractionation regimens on glioblastoma

H. Wheeler, K. McKelvey, A. Hudson, 2022, Radiation oncology.

CA9, CYFIP2 and LGALS3BP—A Novel Biomarker Panel to Aid Prognostication in Glioma

E. Colvin, S. Hayes, V. Howell, 2024, Cancers.